Key statistics
On Friday, Shield Therapeutics PLC (1JS:FRA) closed at 0.046, -29.77% below its 52-week high of 0.0655, set on Sep 04, 2024.
52-week range
Open | 0.037 |
---|---|
High | 0.046 |
Low | 0.037 |
Bid | 0.0365 |
Offer | 0.045 |
Previous close | 0.038 |
Average volume | 23.14k |
---|---|
Shares outstanding | 1.04bn |
Free float | 295.94m |
P/E (TTM) | -- |
Market cap | 37.00m GBP |
EPS (TTM) | -0.0259 GBP |
Data delayed at least 15 minutes, as of Jul 18 2025 14:08 BST.
More ▼
Announcements
- Result of AGM
- Audited results for the year ended 31 Dec 2024
- Licence Agreement in Japan for ACCRUFeR®
- Q1 2025 Trading Update
- ACCRUFeR® launched in Canada
- PDMR Transaction Notification
- Grant of Share Options
- Unaudited full year trading update
- Anders Lundstrom appointed CEO
- Result of General Meeting & Total Voting Rights
More ▼